Epidermal growth factor receptor and S-phase fraction as prognosticator combination in node negative primary breast cancer
- 31 December 1993
- journal article
- Published by Elsevier in The Breast
- Vol. 2 (4) , 229-233
- https://doi.org/10.1016/0960-9776(93)90005-z
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Expression of epidermal growth factor receptor in breast carcinoma.Journal of Clinical Pathology, 1990
- DNA flow cytometry, clinical and morphological parameters as prognostic factors for advanced malignant and borderline ovarian tumorsGynecologic Oncology, 1989
- Epitheliale Wachstumsfaktor-Rezeptoren (EGF-R) und DNA-Flowzytometrie neben Lymphknoten- und Hormonrezeptorstatus als Prognosefaktoren beim primären MammakarzinomGeburtshilfe und Frauenheilkunde, 1989
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Flow-zytophotometrische Parameter, Hormonrezeptoren und axillärer Lymphknotenstatus als Prognosefaktoren beim primären MammakarzinomGeburtshilfe und Frauenheilkunde, 1988
- Quantitative assays of epidermal growth factor receptor in human breast cancer: Cut‐off points of clinical relevanceInternational Journal of Cancer, 1988
- Influence of systematic errors on the evaluation of the S phase portions from DNA distributions of solid tumors as shown for 328 breast carcinomasCytometry, 1987
- Interobserver reproducibility of histopathological features in stage II breast cancerBreast Cancer Research and Treatment, 1985
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958